PD-L1 Positive Non-small Cell Lung Cancer
Also known as: PD-L1 positive Lung Cancer Non-Small Cell Cancer (NSCLC)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14776 | Camrelizumab | 3 | Unknown Status | 1 |
DB00958 | Carboplatin | 3 | Unknown Status | 1 |
DB01229 | Paclitaxel | 3 | Unknown Status | 1 |
DB00642 | Pemetrexed | 3 | Unknown Status | 1 |
DB14765 | Rivoceranib | 3 | Unknown Status | 1 |